Eric Wakshull

2.2k total citations
50 papers, 1.7k citations indexed

About

Eric Wakshull is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Eric Wakshull has authored 50 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 19 papers in Radiology, Nuclear Medicine and Imaging and 19 papers in Immunology. Recurrent topics in Eric Wakshull's work include Monoclonal and Polyclonal Antibodies Research (19 papers), Biosimilars and Bioanalytical Methods (10 papers) and Retinal Diseases and Treatments (6 papers). Eric Wakshull is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (19 papers), Biosimilars and Bioanalytical Methods (10 papers) and Retinal Diseases and Treatments (6 papers). Eric Wakshull collaborates with scholars based in United States, Switzerland and Germany. Eric Wakshull's co-authors include H. Burton, Mary I. Johnson, Walker Wharton, William S. Hancock, Marina Hincapie, Tatiana Plavina, Leslie P. Cousens, Vibha Jawa, Michel Awwad and Anne S. De Groot and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Eric Wakshull

50 papers receiving 1.6k citations

Peers

Countries citing papers authored by Eric Wakshull

Since Specialization

Citations

This map shows the geographic impact of Eric Wakshull's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Wakshull with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Wakshull more than expected).

Fields of papers citing papers by Eric Wakshull

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Wakshull. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Wakshull. The network helps show where Eric Wakshull may publish in the future.

Co-authorship network of co-authors of Eric Wakshull

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Wakshull. A scholar is included among the top collaborators of Eric Wakshull based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Wakshull. Eric Wakshull is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Trends for poorer vision outcomes in nAMD and DME patients with higher aqueous humor levels of IL-6 2019 ·Investigative Ophthalmology & Visual Science ·Yasir J. Sepah, Quan Dong Nguyen, V. Diana, (unknown), Eric Wakshull, Ivaylo Stoilov	4
2	Analysis of the serum and aqueous humor levels of IL-6 in patients with neovascular (wet) age-related macular degeneration (nAMD) receiving anti-vascular endothelial growth factor A monotherapy 2018 ·Investigative Ophthalmology & Visual Science ·Eric Wakshull, Kyu Hong, (unknown), Min Bao, Hugh Lin, Ivaylo Stoilov	1
3	Phase I study of the anti-α5β1 monoclonal antibody MINT1526A with or without bevacizumab in patients with advanced solid tumors 2018 ·Cancer Chemotherapy and Pharmacology ·Colin D. Weekes, Lee S. Rosen, Anna Capasso, Kit Man Wong, Weilan Ye, Maria Anderson, Bruce McCall, Jill Fredrickson, Eric Wakshull, Steve Eppler, (unknown), Rupal Desai, Mahrukh Huseni, Priti S. Hegde, Tony Pourmohamad, Ina Rhee, Alberto Bessudo	15
4	Development and validation of a novel semi-homogenous clinical assay for quantitation of Ranibizumab in human serum 2018 ·Journal of Immunological Methods ·John R. Lowe, Eric Wakshull, (unknown), Anan Chuntharapai, (unknown), Jeriza Rusit, Maurício Maia	11
5	Advancements in Understanding Immunogenicity of Biotherapeutics in the Intraocular Space 2017 ·The AAPS Journal ·Eric Wakshull, Valerie Quarmby, Hanns‐Christian Mahler, (unknown), Dhananjay Jere, Meg Ferrell Ramos, Piotr Szczęsny, Karoline Bechtold-Peters, Sharmila Masli, (unknown)	21
6	Repeat-dose intravitreal administration of a humanized monoclonal antibody is poorly tolerated in rabbits 2015 ·Investigative Ophthalmology & Visual Science ·Christina L. Zuch de Zafra, Cindy Farman, Eric Wakshull, Cinthia V. Pastuskovas, (unknown), Paul E. Miller, Evan A. Thackaberry, Jacqueline M. Miller, (unknown)	1
7	Analysis of 24 month data from the HARBOR study indicates that anti-therapeutic antibodies status had no significant impact on the treatment response to ranibizumab 2013 ·Investigative Ophthalmology & Visual Science ·(unknown), Kha Le, Eric Wakshull, Jeriza Rusit, Jennifer Visich, Jeffrey Nau	2
8	Generation and characterization of a unique reagent that recognizes a panel of recombinant human monoclonal antibody therapeutics in the presence of endogenous human IgG 2013 ·mAbs ·Xiangdan Wang, Valerie Quarmby, Carl Ng, Anan Chuntharapai, (unknown), Charles Eigenbrot, Robert F. Kelley, Steven Shia, Krista McCutcheon, John R. Lowe, (unknown), (unknown), Gary A. Cain, Felix Chu, Isidro Hötzel, Mauricio Maia, Eric Wakshull, Jihong Yang	10
9	T-cell dependent immunogenicity of protein therapeutics: Preclinical assessment and mitigation 2013 ·Clinical Immunology ·Vibha Jawa, Leslie P. Cousens, Michel Awwad, Eric Wakshull, Harald Kropshofer, Anne S. De Groot	193
10	Association of endogenous anti–interferon‐α autoantibodies with decreased interferon‐pathway and disease activity in patients with systemic lupus erythematosus 2011 ·Arthritis & Rheumatism ·Alyssa Morimoto, (unknown), Jihong Yang, Kristen Wolslegel, Xiangdan Wang, (unknown), Alexander R. Abbas, Valerie Quarmby, Eric Wakshull, Bruce Richardson, Michael J. Townsend, Timothy W. Behrens	92
11	Development of a novel homogenous electrochemiluminescence assay for quantitation of ranibizumab in human serum 2010 ·Journal of Pharmaceutical and Biomedical Analysis ·John R. Lowe, Maurício Maia, Eric Wakshull, Patricia Siguenza, Patrick Liu, Sunil R. Lakhani, Jeriza Rusit, (unknown), Valerie Quarmby	10
12	Recommendations for the design, optimization, and qualification of cell-based assays used for the detection of neutralizing antibody responses elicited to biological therapeutics 2007 ·Journal of Immunological Methods ·Shalini Gupta, Stephen R. Indelicato, (unknown), Thomas T. Kawabata, Marian Kelley, Anthony R. Mire‐Sluis, Susan Richards, Bonita Rup, Elizabeth W. Shores, Steven J. Swanson, Eric Wakshull	161
13	Activation of a Rel-A/CEBP-?-related transcription factor heteromer by PGG-Glucan in a murine monocytic cell line 2000 ·Journal of Cellular Biochemistry ·David S. Adams, Robin Nathans, Stephanie C. Pero, (unknown), Eric Wakshull	26
14	PGG-Glucan, a soluble β-(1,3)-glucan, enhances the oxidative burst response, microbicidal activity, and activates an NF-κB-like factor in human PMN: Evidence for a glycosphingolipid β-(1,3)-glucan receptor 1999 ·Immunopharmacology ·Eric Wakshull, Deborah Brunke-Reese, (unknown), (unknown), Robin Nathans, John J. Crowley, (unknown), (unknown), William M. Mackin, David S. Adams	137
15	Promotion of Neutrophil Chemotaxis Through Differential Regulation of β1 and β2 Integrins 1999 ·The Journal of Immunology ·(unknown), Eric Wakshull, Edward J. Filardo, Jorge E. Albina, Jonathan S. Reichner	40
16	Transdermal Drug Transport and Metabolism. II. The Role of Competing Kinetic Events 1989 ·Pharmaceutical Research ·Russell O. Potts, (unknown), Charlene Desbonnet, Eric Wakshull	26
17	Transdermal drug transport and metabolism. I. Comparison of in vitro and in vivo results. 1989 ·Pharmaceutical Research ·(unknown), (unknown), (unknown), Eric Wakshull, Russell O. Potts	36
18	Characterization of the rebinding of ¹²⁵I‐epidermal growth factor released from BALB/c‐3T3 cells following accumulation in the presence of chloroquine 1988 ·Journal of Cellular Physiology ·(unknown), Eric Wakshull, Walker Wharton	3
19	Rapid isolation of plasmalemma from cultured A431 cells: Characterization of epidermal growth factor receptors 1988 ·Analytical Biochemistry ·(unknown), Richard Selinfreund, Eric Wakshull, Walker Wharton	6
20	Stabilized complexes of epidermal growth factor and its receptor on the cell surface stimulate RNA synthesis but not mitogenesis. 1985 ·Proceedings of the National Academy of Sciences ·Eric Wakshull, Walker Wharton	49

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact